APA (7th ed.) Citation

Y, F., R, G., K, J., A, M., A, B., G, T., . . . N, T. (2026). Fusion DNAJB1: :PRKACA in Non-Fibrolamellar Cancer Cases. Reply to Arif et al. Global Re-Analysis Confirms Absence of the DNAJB1::PRKACA Fusion in Hepatoblastoma. Comment on "Fleifil et al. DNAJB1-PKAc Kinase Is Expressed in Young Patients with Pediatric Liver Cancers and Enhances Carcinogenic Pathways. Cancers 2025, 17, 83". Cancers, 18(6), . https://doi.org/10.3390/cancers18060918

Chicago Style (17th ed.) Citation

Y, Fleifil, Gulati R, Jennings K, Miethke A, Bondoc A, Tiao G, Karns R, Timchenko L, and Timchenko N. "Fusion DNAJB1: :PRKACA in Non-Fibrolamellar Cancer Cases. Reply to Arif Et Al. Global Re-Analysis Confirms Absence of the DNAJB1::PRKACA Fusion in Hepatoblastoma. Comment on "Fleifil Et Al. DNAJB1-PKAc Kinase Is Expressed in Young Patients with Pediatric Liver Cancers and Enhances Carcinogenic Pathways. Cancers 2025, 17, 83"." Cancers 18, no. 6 (2026). https://doi.org/10.3390/cancers18060918.

MLA (9th ed.) Citation

Y, Fleifil, et al. "Fusion DNAJB1: :PRKACA in Non-Fibrolamellar Cancer Cases. Reply to Arif Et Al. Global Re-Analysis Confirms Absence of the DNAJB1::PRKACA Fusion in Hepatoblastoma. Comment on "Fleifil Et Al. DNAJB1-PKAc Kinase Is Expressed in Young Patients with Pediatric Liver Cancers and Enhances Carcinogenic Pathways. Cancers 2025, 17, 83"." Cancers, vol. 18, no. 6, 2026, https://doi.org/10.3390/cancers18060918.